首页> 美国卫生研究院文献>Oncotarget >Stim and Orai mediate constitutive Ca2+ entry and control endoplasmic reticulum Ca2+ refilling in primary cultures of colorectal carcinoma cells
【2h】

Stim and Orai mediate constitutive Ca2+ entry and control endoplasmic reticulum Ca2+ refilling in primary cultures of colorectal carcinoma cells

机译:Stim和Orai介导本构Ca2 +进入并控制大肠癌细胞原代培养物中的内质网Ca2 +补充

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Store-operated Ca2+ entry (SOCE) provides a major Ca2+ entry route in cancer cells. SOCE is mediated by the assembly of Stim and Orai proteins at endoplasmic reticulum (ER)-plasma membrane junctions upon depletion of the ER Ca2+ store. Additionally, Stim and Orai proteins underpin constitutive Ca2+ entry in a growing number of cancer cell types due to the partial depletion of their ER Ca2+ reservoir. Herein, we investigated for the first time the structure and function of SOCE in primary cultures of colorectal carcinoma (CRC) established from primary tumor (pCRC) and metastatic lesions (mCRC) of human subjects. Stim1-2 and Orai1-3 transcripts were equally expressed in pCRC and mCRC cells, although Stim1 and Orai3 proteins were up-regulated in mCRC cells. The Mn2+-quenching technique revealed that constitutive Ca2+ entry was significantly enhanced in pCRC cells and was inhibited by the pharmacological and genetic blockade of Stim1, Stim2, Orai1 and Orai3. The larger resting Ca2+ influx in pCRC was associated to their lower ER Ca2+ content as compared to mCRC cells. Pharmacological and genetic blockade of Stim1, Stim2, Orai1 and Orai3 prevented ER-dependent Ca2+ release, thereby suggesting that constitutive SOCE maintains ER Ca2+ levels. Nevertheless, pharmacological and genetic blockade of Stim1, Stim2, Orai1 and Orai3 did not affect CRC cell proliferation and migration. These data provide the first evidence that Stim and Orai proteins mediate constitutive Ca2+ entry and replenish ER with Ca2+ in primary cultures of CRC cells. However, SOCE is not a promising target to design alternative therapies for CRC.
机译:贮藏操作的Ca 2 + 进入(SOCE)提供了癌细胞中主要的Ca 2 + 进入途径。消减ER Ca 2 + 储存时,内质网(ER)-质膜结合处的Stim和Orai蛋白组装可介导SOCE。另外,由于越来越多的ER Ca 2 + 储存库被部分耗尽,Stim和Orai蛋白在越来越多的癌细胞类型中支持组成型Ca 2 + 进入。在本文中,我们首次调查了从人类受试者的原发性肿瘤(pCRC)和转移性病变(mCRC)建立的结直肠癌(CRC)原代培养物中SOCE的结构和功能。 Stim1-2和Orai1-3转录本在pCRC和mCRC细胞中均等表达,尽管Stim1和Orai3蛋白在mCRC细胞中上调。 Mn 2 + 猝灭技术表明,组成性Ca2 + 进入在pCRC细胞中显着增强,并受到Stim1,Stim2,Orai1和Orai3的药理和遗传学阻断。与mCRC细胞相比,pCRC中较​​大的静息Ca 2 + 流入量与其较低的ER Ca 2 + 含量有关。 Stim1,Stim2,Orai1和Orai3的药理和遗传阻滞阻止了ER依赖性Ca 2 + 的释放,从而提示本构SOCE维持ER Ca 2 + 的水平。尽管如此,Stim1,Stim2,Orai1和Orai3的药理和遗传阻滞作用并未影响CRC细胞的增殖和迁移。这些数据提供了第一个证据,表明Stim和Orai蛋白介导组成性Ca 2 + 进入,并在CRC细胞的原代培养物中补充Ca 2 + 。但是,SOCE并不是为CRC设计替代疗法的有希望的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号